Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Research into Cold Cancers Heating Up

Activation and expansion are essential for success in both autologous and allogeneic therapies.

Development of Gamma-Delta T-Cell Therapies

Continuous manufacturing and a quality-by-design development approach are a natural fit.

QbD for Small-Molecule Continuous Process Development

Topic

Webcasts

Webinar Date/Time: Tue, Aug 27, 2024 | 11:00 AM EDT | 4:00 PM BST


Flexible-Dose Development Strategies for Today's Clinical Landscape

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

Weighing development costs/resources and performance benefits is essential.

Biobetter Development

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

The increased demand for biopharmaceutical products is increasing the demand for lyophilization innovations and services.

The Rising Iceberg of Lyophilized Innovations

Joe Petroziello is Executive Vice President, Head of Global Medical Affairs & Corporate Development at MJH Life Sciences.

Shawn Davis, CEO of Liberate Bio, shares some insights into the world of drug discovery, development, and delivery, as well as process optimization 

Improving the Efficacy of Genetic Medicines

Feliza Mirasol is the science editor for 

LenioBio and Labscoop's new strategic partnership is aimed at increasing access to scalable cell-free protein synthesis technology across North America.

Cell-Free Protein Synthesis Technology to be Made More Accessible Through LenioBio and Labscoop Partnership

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

Kisunla (donanemab-azbt) reduced amyloid plaques in Phase III study participants by 84% after 18 months.

FDA Approves Lilly Treatment for Early Symptomatic Alzheimer’s Disease

Mike Hennessy Jr. is the President and CEO of 

A greater number of patients with Duchenne muscular dystrophy will be able to be treated after FDA's approval of a gene therapy.

Publisher's Note: With Age Comes Wisdom

The company is referring to its search for innovative approaches as crowdsourcing and will award at least one cash prize.

Angelini Pharma Seeks Solutions for New Drug Delivery Systems and Treatments

Webinar Date/Time: Thu, Jul 25, 2024 11:00 AM EDT


Delving into Biopharmaceutical Development and Manufacturing

Life sciences data sets can be vast and complex to process, but up to now bringing intelligent automation systems up to speed and validating them has felt debilitatingly onerous. Large language models tackle these barriers head on. Ramesh Ramani and RaviKanth Valigari, technology innovators at ArisGlobal, explain.